Jim Simons Alx Oncology Holdings Inc Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 85,399 shares of ALXO stock, worth $140,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,399
Previous 14,299
497.24%
Holding current value
$140,054
Previous $8,000
337.5%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALXO
# of Institutions
68Shares Held
31.6MCall Options Held
53.8KPut Options Held
11.7K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$15.9 Million4.29% of portfolio
-
Redmile Group, LLC San Francisco, CA3.39MShares$5.56 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA3.16MShares$5.18 Million0.08% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$4.41 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA2.54MShares$4.16 Million0.5% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $66.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...